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1 Introduction 
 
The goal of this thesis was to design an automated test sequence to be used in the 
manufacturing line, to verify the dose reproducibility and linearity of the Mammography 
system. Thesis was made for GE Healthcare Finland Oy. GE Healthcare is one of the 
world’s leading medical technology companies. GE Healthcare has over 50 000 employ-
ees around the world, where over 750 work in Finland. [1] GE Healthcare Finland focuses 
on anaesthesia and respiratory care units. Advanced Manufacturing Engineering (AME) 
Test department in Finland is designing a new mammography testing equipment for GE 
Healthcare’s manufacturing line in Buc, France.  
 
Breast cancer, after lung cancer is the second most fatal cancer for women. Key in de-
creasing the deaths caused by breast cancer is mammography screening. In mammog-
raphy screening, a large group of women are called for mammograms to see if women 
have cancer cells in the breast tissue or even a cancer tumour. Mammography screening 
made in the early phase of the cancer decreases the death rate from breast cancer. [2] 
 
Old mammography systems were based on film-screen technology. This involved cas-
settes of film to be placed on top of the detector, and this film was then developed so 
that the radiologist could examine the image. This technology has been replaced with 
the digitalization of mammography, where the screen-film was replaced by a digital de-
tector. Digital mammography has been able to decrease the dose from the x-ray expo-
sure as well as increase the image quality, to improve the overall quality of mammogra-
phy. 
 
GE Healthcare manufactures many mammography products. These products need to be 
tested on the manufacturing line to be compliant with medical standards and regulations. 
The Dose Reproducibility and Linearity is one of the tests that focus on the dose from 
the x-ray exposure. Dose for the patient shall be kept as low as reasonably achievable 
and consistent between the exposures. 
 
Dose Reproducibility and Linearity test is a part of the automated tests that shall be done 
in the manufacturing line to test mammography systems. Test sequence was made with 
TestStand and LabVIEW software, which are developed by the National Instruments. 
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2 Theory of X-Ray Mammography 
 
Theory behind this thesis includes several factors concerning the x-ray characteristics, 
which affect the absorbed dose for the patient. Mammography is explained and the main 
focus will be on the digital systems, but film-screen mammography is also discussed. 
Regulations and standards of the medical business are of high importance, so the main 
regulations and standards concerning mammography are discussed and explained. 
 
2.1 X-Ray in Mammography 
 
X-ray radiation is electromagnetic radiation that has a quality of passing through many 
materials that are opaque to light, which is due to its high energy and short wavelength 
of 0.1 to 10 nanometres. [3] 
 
X-rays are widely used in medical industry for imaging the inner organs, bones and in 
search of tumours inside the human body such as cancer in the breast. 
 
X-ray tube is made of glass and inside there is a vacuum. Inside of the glass chamber, 
there are two main parts, anode and cathode. A high-voltage is connected to the tube 
and the positive pole is connected to the anode. Design for the x-ray tube can be seen 
in the figure 1.  [4] 
 
 
Figure 1 Mammography X-ray tube 
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Anode is a shaft that has rotor inside the x-ray tube. Outside of the tube, there is stator 
that is connected to AC voltage, which causes alternating magnetic fields and turns the 
rotor. Cathode is connected to the negative pole, so that the electrons inside the tube 
are going from cathode to the anode with high velocity.  
 
Cathode has two wire filaments inside of it. Filaments are heated up with so called fila-
ment current and when the filament heats up it emits electrons. As electrons are emitted 
from cathode filament, the high-voltage connected to the anode and cathode makes 
these electrons to accelerate towards the anode. When these electrons hit the focal spot 
of the anode they produce x-rays. [4] 
 
2.1.1 X-Ray Exposure 
 
When x-rays interact with matter, they cause ionization. X-rays can be measured with an 
ionization chamber which is filled with air and on the outer sides there are positive and 
negative electrodes. The device is called Dosimeter, which is shown in the figure 2 be-
low. 
 
 
Figure 2 Dosimeter  
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When x-rays interact with the air molecules in the chamber, they ionize and the electrons 
are collected on the positive electrode and negative electrode collects the positive ions.  
 
Exposure X is a deviation of the ionized electrons in air, which have an electrical charge 
Q, which is divided by the mass of the air. As shown in the formula 1 below. 
 
𝑋 =  𝑄 𝑚⁄      (1) 
 
[5,54] 
 
The measurement unit of the exposure is roentgen [R], where: 
 
1 R = 2.58 x 10-4 C/kg    (2) 
 
Unit is Coulomb per kilogram. With a 1-R exposure, air absorbs energy as the formula 3 
shows: 
 
 2.58 x 10-4 C/kg x 33.97 J/C = 0.00876 J/kg = 87.6 ergs/g (3) 
 
Where 33.97 Joule per Coulomb is an average energy to produce ion pair in air and erg 
is a unit of 10−7 Joule. An exposure can be converted into the dose absorbed by the air 
Dair since 1 R = 100 ergs/g: 
 
 Dair = 0.876X     (4) 
 
Joule per kilogram is one Gray, then 1 Gy = 100 Rads, this 1-R exposure produces a 
dose in the air of 8.76 mGy. If the x-rays are absorbed in other matter than air, the equa-
tion can be derived to: 
 
 Dmed = f X     (5) 
 
Where f is the factor determining the energy-dependency of the material and X stands 
for exposure. In Europe exposure is usually defined as air Kerma which stands for kinetic 
energy released per unit mass. Air Kerma is the sum of charged particles that release 
kinetic energy to a unit mass, in this case to air. [4] 
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2.1.2 Equivalent Dose 
 
Relative biological effectiveness is used to define biological harm for the human body. 
Different radiation types have different RBE based on their characteristics. X-ray of 1 
mGy has lower RBE than for example alpha particle with 1 mGy. That’s why equivalent 
dose is used. It is defined as: 
 
 H = wrD,     (6) 
 
D stands for the dose in unit of Grays, and wr is a weighting factor that defines the radi-
ation used to deliver the dose D. X-rays used in radiology have wr of 1, when for example 
alpha particles have a weighting factor of 20. The unit for equivalent dose is Sievert (Sv) 
and one Sievert is 1 J kg-1. [5,56] 
 
2.1.3 Effective Dose 
 
In most cases of radiology, only small part of human body is used for imaging. That’s 
why there is the effective dose E, which scales the equivalent dose to the small portion 
of the body. For effective dose, the wt is weighting factor for tissue, so the equivalent 
dose can be measured for each type of tissue: 
 
𝐸 = ∑ 𝑤𝑡 𝐻𝑡
𝑁
𝑡=0      (7) 
 
Effective dose is also displayed as Sieverts. Tissue weighting factors are for example: 
Breast = 0.05, Lungs = 0.12 and skin = 0.01. [Values from table 1.8] 
 
2.1.4 Half-Value Layer 
 
Half-value layer is a term to measure attenuation of the exposure through material. It is 
usually calculated using aluminium. HVL calculates the aluminium thickness needed to 
reduce exposure to half. HVL is only measured with an air-filled exposure meter, be-
cause other systems will give different results since exposure is defined in air only. When 
using higher tube voltage the HVL value will increase and with a lower tube voltage the 
HVL value decreases, since the x-rays attenuate more in thicker material. 
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2.1.5 Typical Breast Dose 
 
Typical dose that is absorbed by the breast can be simulated with a phantom block that 
is made of polymethylmethacrylate (PMMA) which is acrylic glass, simulating the breast 
and using the normal parameters of exposures selected in a mammography exam. A 
phantom made of PMMA is shown in the figure 3 below. [6,157] 
 
 
Figure 3 Phantom block made of PMMA. 
 
PMMA is not identical to the breast tissue, since it’s denser but they both have similar 
attenuation factors, this is why it is the most used material to simulate the breast in mam-
mography. 
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To calculate the average dose absorbed to breast tissue, multiple exposures with differ-
ent PMMA thicknesses are needed. Thicknesses are specified in European Guidelines 
for Quality Assurance in Breast Screening and Diagnosis to be from 20 mm to 70 mm 
with an increment of 10 mm. Average glandular dose can be then calculated with a for-
mula of: 
 
D = Kgcs     (8) 
 
Average glandular dose is D, K is for air Kerma, and g-factor is a value of 50 % out of 
glandular tissue. Values of the g-factor can be found from the table 1. C-factor is also 50 
% of glandular tissue, this needs to be taken in to account when using PMMA since it 
has different characteristics than normal breast tissue. Values for c-factor can be found 
from the table 2. S stands for dose level in typical simulated breast and the values for it 
can be found from table 3. [6,157] 
 
Table 1 g-factors for breast simulated with PMMA [6, Table A5.1] 
PMMA 
thickness 
(mm) 
Equivalent 
breast thick-
ness (mm) 
g-factor (mGy /mGy) 
HVL (mm Al) 
0.30 0.40 0.50 0.60 0.70 
30 32 0.261 0.326 0.388 0.448 0.495 
50 60 0.135 0.172 0.214 0.261 0.300 
70 90 0.086 0.111 0.136 0.172 0.202 
 
To correct the difference from the PMMA material the c-factor with a 50% glandular tis-
sue is used. C-factors can be found from the table 2 below. 
 
Table 2 c-factors for breast simulated with PMMA  
*(c-factor for typical breasts for women in the age of 50 to 64) [6, Table A5.2] 
PMMA 
thickness 
(mm) 
Equivalent 
breast thick-
ness (mm) 
Glandular tissue of 
equivalent breast 
(%) 
c-factor * 
HVL (mm Al) 
0.30 0.40 0.50 0.60 0.70 
30 32 67 0.940 0.945 0.949 0.953 0.959 
50 60 20 1.164 1.151 1.144 1.134 1.117 
70 90 4 1.299 1.282 1.270 1.249 1.225 
 
Dose levels for typical breasts simulated with PMMA phantom can be seen from the table 
3 which is taken from the European Guidelines for Quality Assurance in Breast Screening 
and Diagnosis. 
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Table 3 Dose levels for typical breasts simulated with PMMA [6, Table on page 83] 
Thickness of PMMA 
(mm) 
Equivalent breast 
thickness (mm) 
Maximum average glandular dose to equiv-
alent breasts (mGy) 
Acceptable level Achievable level 
30 32 ≤ 1.5 ≤ 1.0 
50 60 ≤ 3.0 ≤ 2.4 
70 90 ≤ 6.5 ≤ 5.1 
  
Table 3 shows that the dose for the equivalent breast simulated by the PMMA phantom 
is inside the acceptable level.  
 
2.2 Mammography 
 
Mammography is a medical imaging technique that serves a key role in detecting breast 
cancer at its early phase. For this purpose many trials of mammography screening were 
performed. Over the years many screenings have shown that the mammography exam-
inations decrease the mortality of breast cancer. GE Senographe Essential Mammogra-
phy system is shown in the figure 4 below. 
 
Figure 4 GE Senographe Essential Mammography System Copied from ge.com [7] 
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In mammography exam the breast is compressed with a paddle, so that the breast tissue 
is evened out in order to acquire an image that has no intertwining tissues that could 
hide cancer. 
 
Old mammography method used a film-screen detector to acquire the image and the film 
was also used for showing the image to the radiologist. Digitalization removed this film 
with a digital detector that can transmit the image to the computer that has a specific 
monitor for radiological purposes. This means better contrast, better image quality and 
for the patient, the lower dose. 
 
Screen-Film mammography system has three main parts. In mammography examination 
the first part is taking the image of the breast, which is often called as image acquisition. 
Then the captured image on film must be shown to the radiologist to analyse the breast 
for lesions. Then the image screen will be stored in an archive. So the three parts are 
image acquisition, displaying the image and storing the image taken. 
 
In mammography the images can be taken with a reasonably low dose to the patient, 
because of the development of the mammography systems. The most advanced tech-
nology achievement that has helped in this progression is the digitalization of mammog-
raphy. 
 
There has been numerous trials to test out the differences of film-screen mammography 
and the digital mammography. The main difference between the film-screen and digital 
mammography was that the digital mammography has an advantage in specific groups 
of women which include women with dense breasts, younger women and women in 
premenopausal. 
 
In digital mammography system, all of the parts are linked with the digital acquisition of 
the image, which can be shown on the computer screen to the radiologist and then stored 
in a database. If the image acquired is not sufficient enough for radiological purposes on 
its own, the computer can adjust the image to be more informative to the radiologist. 
Image properties can be adjusted, such as image contrast or zooming into parts of the 
image [8, 4]. 
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2.2.1 Digital Mammography 
 
In digital mammography systems a digital detector is used. Since the captured x-ray 
image is in digital format, the image data is described in pixels. Pixels lined in some 
shape make a matrix of pixels that displays the image. The images acquired by the digital 
detector display the breast tissue with different volumes as shades of grey. [8, 9] 
 
In mammography images there are two properties that need to be thought of: noise and 
practical contrast. In film-screen mammography the practical contrast is more critical 
since the contrast cannot be altered afterwards like in digital mammography. In digital 
mammography where the contrast can be altered, the lack of noise in the image is more 
important. 
 
Quantum Noise is a term that comes from the changing number of x-rays attenuated 
around the breast tissue. Standard deviation for Quantum Noise is: 
 
 σ = √(𝑛)     (9) 
 
The n in the formula is the average of the number of x-rays in specified region of breast. 
This n is the number of x-rays that will produce the image to the detector and it can be 
referred to as nd. This number must be increased to improve the clearness of the image 
i.e. reduce noise. The chosen current-time product (mAs) affects this number by direct 
relation. Increasing current-time product increases the number of x-rays that will produce 
the image to the detector. 
 
To reduce the noise of the image, it is needed to understand the concept of signal-to-
noise-ratio (SNR), which is a ratio of σ and nd: 
 
 SNR = 
(𝑛𝑑)
√(𝑛𝑑)
=  √(𝑛𝑑)    (10) 
 
By increasing the current-time product SNR is increased, therefore resulting to a clearer 
image. [9, 6 (formula 1.8)]  
 
Spectrum of the x-ray is based on two parameters of the x-ray tube, the filter and the 
voltage. Filter metal which is often Molybdenum or Rhodium filters the beam and the high 
voltage activates the tube, which results in an exposure.  
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In screen-film mammography the average parameters of Molybdenum filter, Molyb-
denum target and a voltage of 26 kV create a significantly higher dose into the average 
breast to get higher value of SNR. Digital mammography can use higher energies to 
lower the dose and still maintain the SNR at acceptable level. With higher energy, the x-
rays will penetrate the tissue better, then resulting in lower dose absorbed by the breast 
tissue. 
 
Digital mammography is significantly lowering the dose of the exposures, when still main-
taining the image quality and the diagnostic value. [9,6,10] 
 
2.3 Regulations and Standards 
 
Mammography is a highly regulated area with all the other medical imaging techniques.  
 
The American College of Radiology (ACR) has made an accreditation program to ensure 
that all the facilities performing mammography have highest quality of care for the pa-
tient. This accreditation program is used in the United States. 
 
Food and Drug Administration (FDA) has made many regulations to make sure that the 
quality of the mammography systems is the best possible so that the risks for the patient 
are low as possible. Mammography Quality Standards Act includes all of these regula-
tions. Code Federal Regulation 900 1020 Part 900 implements the regulations set in the 
MQSA (42 U.S.C 263b). 
 
Also European Union has made guidelines to assure the quality of the mammography 
screenings and diagnosis inside the EU. 
 
2.3.1 American College of Radiology Accreditation Program 
 
The American College of Radiology established an accreditation program in 1987 to 
make sure that all the facilities performing mammography screening or diagnosis are 
providing highest quality of breast care. This accreditation program includes the stand-
ards for personnel, equipment, quality assurance, clinical images, phantom images and 
dose. 
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More and more facilities started to apply for accreditation and in 1991 twenty-five percent 
of mammography facilities had succeeded in accreditation program. Growing number of 
mammography facilities started to get successful accreditation so that they meet the 
standards set in the program and States started to demand that facilities pass the ac-
creditation. 
 
In 1990 screening mammography was authorized to be in Medicare coverage by the 
United States Congress. To be in the Medicare the facility needed to pass quality tests 
made by the Health Care Financing Administrator. The standards made by the Health 
Care Financing Administrator had similarities with the ACR accreditation programs 
standards. In 1992 federal administrators started to supervise the screening facilities.  
 
Since states, federal governments and other institutions such as ACR were monitoring 
the quality of mammography, the need for a nation-wide standards was increasing. In 
1992 the Congress of United States passed the Mammography Quality Standards Act 
(MQSA). [10] 
 
2.3.2 Mammography Quality Standards Act  
 
Mammography Quality Standards Act was created by the U.S Food and Drug Adminis-
trator (FDA) so that all the mammography facilities met the minimum requirements for 
standards and quality. These requirements included personnel, equipment and record-
keeping. Also the facility had to be certified by the FDA or an FDA-approved state certi-
fying body. 
 
FDA made a schedule that all the facilities in the United States must be certified and 
accredited by the MQSA by 1st of October 1994. Because of this FDA needed to make 
better rules for certification to get all the mammography facilities accredited, and on 21st 
of December 1993 FDA published the “Mammography Facilities – Requirements for Ac-
crediting Bodies and Quality Standards and Certification Requirements”. These rules in-
cluded many standards found in the ACR accreditation program and also from the ones 
found in Health Care Financing Administrators. 
 
MQSA was corrected and improved over the years, but the final regulations were pub-
lished on October 28, 1997 by the FDA. All the previous requirements were included but 
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with more in-depth knowledge and made more specific requirements on equipment and 
personnel standards. This final regulation was updated in 2002 to be more specific about 
equipment. [10] 
 
2.3.3 Mammography Standard (CFR 21 900 1020) 
 
This Code Federal Regulation implements the regulations set in the MQSA. This regula-
tion describes the accreditation process for facilities performing mammography. All facil-
ities shall have an annual survey so that they meet the standards set in the CFR 21 900 
1020. Also the accreditation bodies oversee the quality control programs of the facilities. 
 
Mammography equipment’s performance is evaluated by the regulation published under 
§§ 1020.30, 1020.32 and 900.12(e). All mammography systems shall provide factors 
about the parameters used in taking the exposure, these include kilovolts (kV) and tube 
current (mA), also when using the automatic exposure controls (AEC) these parameters 
shall be seen after taking the exposure. All mammography systems shall have an AEC 
mode which takes into account all of the combinations of grid and magnification equip-
ment. 
 
Regulation sets the value of dose to average glandular tissue simulated by the FDA-
accepted phantom which simulates the standard breast. This dose value shall be lower 
than 3.0 milligray (mGy). The radiation of the system shall be capable of outputting at 
minimum a 7.0 mGy air Kerma per second with parameters of 28 kVp and molybdenum 
as the track and filter material. Dosimeters used by the facilities should be calibrated 
every 2 years to ensure the accuracy and confidence level of 95 percent. 
 
Part 1020 is about the performance standards for ionizing radiation emitting products. In 
this part the compliance testing of mammography devices is discussed. Reproducibility 
and linearity have its own specifications which are described as follows. 
 
Reproducibility of the equipment is discussed under this standard. The variation of air 
Kerma shall be no greater than 0.05 for any given technique factors selected. Reproduc-
ibility is examined by taking 10 consecutive exposures in a time window of 1 hour. Mam-
mography equipment having an automatic exposure control shall be tested for compli-
ance with a material with appropriate thickness to have correct attenuation level. 
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Linearity of the current-time product is regulated so that the average ratio from air Kerma 
and current-time product (mGy/mAs) shall be obtained from two exposures with current-
time products being two consecutive values available. The ratio shall not be more than 
0.10. With these two consecutive settings of current-time products, 10 exposures shall 
be taken in less than 1 hour. Focal spots for the two current-time products have limita-
tions. Two focal spots shall not have one less than 0.45 mm and one greater than 0.45 
mm, any other focal spot sizes are acceptable. [11] 
 
2.3.4 Medical Device Design Standard (IEC 60601-1 3rd edition) 
 
International Electrotechnical Commission has published standards for Medical Device 
Design. IEC 60601-1 3rd edition contains compliance requirements for x-ray equipment.  
 
Mammography equipment shall indicate x-ray radiation dose to the patient in two ways, 
which are entrance air Kerma and average glandular dose. X-ray equipment has to be 
designed in a way that it delivers safe and effective treatment with x-ray radiation man-
agement. 
 
X-ray equipment needs to have possibility to restrict the radiation dose to the patient and 
that the quality of the radiation can be modified to serve the intended use of the x-ray 
equipment. 
 
Mammography equipment shall have documentation about the accuracy of the radiation 
output. Linearity of the air Kerma for mammography equipment needs to be in line with 
the chosen current-time product selected. Accuracy of the linearity shall be better or 
equal to 0.2. Note that this value is bigger than the value specified in the FDA regulations. 
Reproducibility for the measured air Kerma shall not exceed 0.05 with any exposure 
parameters selected. 
 
The accuracy of the equipment is very critical. X-ray tube voltage needs to be accurate 
with every exposure. For testing the reproducibility of the tube voltage exposures with 30 
kV, lowest voltage available and the highest voltage available shall be used and the 
current-time products shall be the lowest, a medium and the highest values. 10 expo-
sures with these parameters, with a total of 30 exposures shall be taken, where 10 ex-
posures should be taken in less than 1 hour. After exposures the coefficient of variation 
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for the average value shall be calculated. This value verifies the reproducibility and com-
pliance of the x-ray tube. 
 
Current-time products accuracy shall be tested with two exposures. Parameters for the 
first exposure shall have the lowest current-time product available, together with the high-
est possible tube voltage. Second exposure shall have inverted parameters, so that the 
highest current-time product is used with lowest tube voltage. 
 
Automatic exposure control shall be tested for reproducibility with repeated exposures of 
an approved phantom where the current-time product air Kerma and the average pixel 
values need to be within specifications set in this standard. 
 
If the operator cannot set the parameters for the exposure as the equipment is intended, 
then the automatic control system shall be used. The use of automatic exposure controls 
shall be determined by the particular standard, which is explained in the FDA CFR 
21 900 1020. 
 
The dose that is absorbed into the patient shall be kept as low as reasonably achievable 
(ALARA), so that the dose for the patient is never unnecessarily high. [12] 
 
2.3.5 European Guidelines 
 
The European Parliament has declared that there shall be an accreditation program that 
will include all the members of the European Union. This declaration specifies that all 
countries in the EU shall provide high-quality breast care for women. 
 
To assure that these declarations fulfil their goal, the European Guidelines for Quality 
Assurance in Breast Screening and Diagnosis was created. The most current version is 
the fourth edition published in 2006 by N. Perry et al. 
 
Statistics show that the breast cancer has the highest mortality rate in women over the 
age of 50. Because of this the European Parliament made a resolution in June 2003 (OJ 
C 68 E, 2004) to set breast cancer as a top priority health risk that should be lowered 
and effectively tackled. [6] 
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3 Dose Reproducibility & Linearity Test 
 
Reproducibility indicates the measurement precision or the reliability of tested equip-
ment. 
 
The quality control of mammography systems are focusing heavily on the reproducibility 
and consistency of the imaging system. For every exposure made, the correct parame-
ters used must be in very narrow tolerance limits. In mammography it is important that 
the parameters that are used match the settings specified, so that retaking exposures 
are avoided and the dose for the patient is as low as reasonably achievable.  
 
Scope of the test for Dose Reproducibility and Linearity is to verify that: 
- The reproducibility of the dose (for the manual and automatic mode) 
- The linearity of the dose 
are compliant with United States regulations. 
 
3.1 Test Requirement Specifications 
 
Test requirements include testing equipment and other materials to be used in the test. 
This document is divided into multiple sections. The sections are: pre-requisites, required 
materials, testing procedure and test specifications. 
 
First the pre-requisites are defined for the test. For Dose Reproducibility and Linearity 
the pre-requisites are that the system must be fully calibrated and that all the tests prior 
to this are made successfully. 
 
Required materials is the second part. In this test the materials required include a Do-
simeter with an ionization chamber of 6 cc. For simulating the breast, it is required to use 
lucite plates, also known as PMMA acrylic glass. Properties of the PMMA shall be 40 
mm thick at minimum and 10 cm x 10 cm dimensions at minimum. On top of the detector 
there shall be a steel plate to protect the detector, since in this test the image is not 
relevant. Also in this test a Bucky and paddle are needed. Bucky is a device which pro-
tects the detector and has a grid inside that decreases the scattered radiation of the x-
rays. 
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Testing procedure is described as follows: 
 
Operator must first place the Bucky on top of the detector, then place dosimeter, steel 
plate and the lucite plate on top of the Bucky in the specified tool. Lucite plates shall then 
be compressed with a force of 5 deka Newton [daN]. Field of View shall be 24 cm x 29 
cm and the tube arm shall be at 0 degrees. 10 exposures shall be taken for each test 
and they shall be taken in less than an hour. 
 
There are four tests where in each of them, 10 exposures are taken. These tests are 
Reproducibility with manual mode and automatic mode and two times linearity where 
different current-time product is used. In all of those tests the dose values are measured 
with a dosimeter and recorded. 
 
Dose Reproducibility with manual mode shall be executed so that 10 exposures are 
taken with a current-time product of 4 mAs. From the measured doses, the reproducibility 
is calculated with the formulas below: 
 
𝐴𝑉𝐸𝑅𝐴𝐺𝐸 =  
∑ 𝐷𝑂𝑆𝐸𝑘𝑛𝑘=1
𝑛
     (11) 
 
σ = √
∑ (𝐷𝑂𝑆𝐸𝑘 −𝐴𝑉𝐸𝑅𝐴𝐺𝐸)2
𝑛
𝑘=1
𝑛−1
    (12) 
 
 𝐶1 =
 σ
𝐴𝑉𝐸𝑅𝐴𝐺𝐸
    (13) 
 
Where n is the number of exposure and AVERAGE is the average dose calculated from 
the 10 dose values, σ is sigma and C1 is the reproducibility. 
 
Same procedure is applied with the automatic mode but in there the exposure parame-
ters are chosen automatically by the system. This is done by algorithms which take the 
thickness of the material compressed, the compression force and then calculate the pa-
rameters that are best suited for that type of ‘breast’. 
 
In Dose Linearity the procedure is so that 10 exposures are taken with 4 mAs and then 
10 exposures are taken with the next current-time product available which is 4.5 mAs. 
From there we get two M_config values that are used to calculate the linearity of the 
dose. Formulas are shown below: 
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𝐴𝑉𝐸𝑅𝐴𝐺𝐸 =  
∑ 𝐷𝑂𝑆𝐸𝑘
𝑛
𝑘=1
𝑛
     (11) 
 
M_config1=
𝐴𝑉𝐸𝑅𝐴𝐺𝐸𝐶𝑜𝑛𝑓𝑖𝑔1
𝑚𝐴𝑠𝐶𝑜𝑛𝑓𝑖𝑔1
    (14) 
 
M_config2=
𝐴𝑉𝐸𝑅𝐴𝐺𝐸𝐶𝑜𝑛𝑓𝑖𝑔2
𝑚𝐴𝑠𝐶𝑜𝑛𝑓𝑖𝑔2
    (15) 
 
L = 
| 𝑀𝐶𝑜𝑛𝑓𝑖𝑔1− 𝑀𝐶𝑜𝑛𝑓𝑖𝑔2|
𝑀𝐶𝑜𝑛𝑓𝑖𝑔1+ 𝑀𝐶𝑜𝑛𝑓𝑖𝑔2
    (16) 
 
Where n is the number of exposures taken, AVERAGEconfigs are the dose averages 
from the 10 exposures taken in configurations 1 and 2. mAsConfigs are the current-time 
products which are 4mAs and 4.5mAs. L is for Linearity. 
 
The test specifications are: 
- Dose Reproducibility C1, manual mode shall be lower than 0.05 
- Dose Reproducibility C2, automatic mode shall be lower than 0.05 
- Dose Linearity L, shall be lower than 0.1 
 
These specifications mentioned above are not including any potential inaccuracy due to 
the measurement process and due to the manufacturing tool. 
 
3.2 Test Sequence 
 
Test Sequence is developed with TestStand 2010, which is a program made by the Na-
tional Instruments. National Instruments TestStand is a test management software 
where engineers can manage and run automated tests for the system under test. 
 
TestStand sequences have three parts which are: 
- Setup, where the test system is configured and setup. This can contain parameter 
configurations, check that all connections are made correctly etc. 
- Main, this part contains all the steps specific to the test ongoing. 
- Cleanup, where the system is configured back to the state which it was before 
the test was launched. Connections are shut down, the system is restored to its 
original state. 
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TestStand structure with Setup-, Main- and Cleanup parts are illustrated in the flow dia-
gram. Setup, Main and Cleanup are inside every sequence section, including the subse-
quences which are displayed as orange in the figure 5. 
 
 
Figure 5 Flow diagram of the TestStand sequence structure. 
Sequence Setup 
 
Sequence Main 
 
Cleanup 
Setup Main Cleanup 
Setup Main 
Dose Reproducibility Manual Mode 
Dose Linearity Configuration 1 
Dose Linearity Configuration 2 
Sequence Cleanup 
Dose Reproducibility Automatic Mode 
Setup Main Cleanup 
Setup Cleanup Main 
Setup Cleanup Main 
Setup Cleanup Main 
Setup Cleanup Main 
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TestStand interface has five main panels, which are Insertion Palette, Steps, Variables, 
Sequences and Step Settings. TestStand interface is shown in the figure 6. 
 
 
Figure 6 TestStand interface example 
 
Insertion Palette which is on the left side of the interface, contains all the possible steps 
that can be used in the sequence.  
 
Steps panel is in the middle which shows the sequence structure when all the used steps 
are inserted in a sequential order from top to bottom.  
 
Variables contain all the variables used in the sequence. Variables can be local in the 
sequence, Parameters which are used when information is passing in or out of a subse-
quence or step. FileGlobals are variables that are shared between the whole sequence 
file. StationGlobals are variables that are shared within the used station e.g the operator 
pc. 
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Sequences has all the sub sequences inside the whole sequence. Main Sequence on 
top has all the other sequences inside of it and has the structure explained in the begin-
ning of this chapter. 
 
Step Settings has the step-specific properties shown. All the variables used, precondi-
tions, expressions, post-actions etc. 
 
All the subsequences are made by this structure explained in the beginning of this chap-
ter, so that the so called upper level setup and cleanup are the same for all the test 
sequences but in the Main there is only parts that are relevant for this specific test. 
 
In the setup for Dose Reproducibility and Linearity test which is shown in the figure 7 
below, the start of logging the messages for the sequence execution is made. CAN-bus 
communication is started, so that it is possible to read messages from the unit under test 
(UUT) via CAN-bus.  
 
 
Figure 7 TestStand code for Sequence Setup 
 
CAN is a Controlled Area Network communication protocol which will display data when 
a triggering effect is used, for example in mammography the arm of the system started 
movement, then the CAN-bus will indicate that the movement started. In this test it is 
used to read all the system emergency errors that will lead to halting the system. 
 
Dosimeter communication which uses serial bus, is turned on in the setup. After this the 
Dosimeter is initialized so that it can be used in the test. This initialization is basically so 
that the dosimeter is configured to use Dose Cumulative-mode. This means that the dose 
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acquired by the dosimeter is added to value taken before. Because of this mode in the 
dosimeter, the dose for individual exposure needs to be extracted from the cumulative 
dose value. This is explained in the upcoming parts of the thesis. 
 
System needs to be setup for the test. This means that the arm of the mammography 
device needs to be at 0 degree angle, with no compression and no angulation. A pop up 
message for the operator is used, to inform the operator that he or she needs to put the 
specified equipment on the system. 
 
Equipment in this test has the paddle so that compression can be applied, steel plate so 
that the detector is protected from the unnecessary x-rays. On top of the steel plate, a 
device which has the lucite plates and a slot for the dosimeter is placed. The dosimeter 
needs to be placed only 5 cm into the field of view, so this kind of tool is placed on the 
detector that the dosimeter is always in the correct place. Tool is shown in the figure 8. 
 
 
Figure 8 Dose Reproducibility tool which includes a stand for Dosimeter and lucite plate. 
 
When all the equipment and tools are placed for the test, compression of approximately 
5 daN is applied and the field of view is set to the maximum of 24 cm x 29 cm. 
 
Automated user interface test program is used to create a patient on the operator pc. All 
tests are ran from a specified testing PC. With the actual mammography device there is 
the operator PC which the operator uses for adding patient to the database, set param-
eters for exposures and review the images acquired. A connection by Secure Shell net-
work (SSH) is used between the test bench and the operator PC. This program is used 
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in a way that the user interactions, in this case creating the patient, is recorded by the 
software and this recording is scripted into a Python code. This recorded Python script 
is then played and the user interface interactions are made by the software. This part 
ends the setup for this test. 
 
 
Figure 9 Sequence Main 
 
In the Main part of the test, which is seen in the figure 9, there are four sections for all of 
the parts that need to be tested. These steps are the dose reproducibility with manual 
mode (Step 1), two times the linearity of the dose with two different current-time product 
configurations (Steps 2, 3) and the dose reproducibility with automatic mode (Step 4). All 
four steps are sequence calls to a subsequences inside the whole test sequence. Sub-
sequence is like a module that’s inside the whole structure. 
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3.2.1 Dose Reproducibility Manual Mode 
 
Dose reproducibility with manual mode is a subsequence inside the Main of the whole 
sequence. This subsequence has setup, main and cleanup as in the upper level se-
quence. Setup is shown in the figure 10 below. 
 
 
Figure 10 Dose Reproducibility Manual mode subsequence setup. 
 
First the connection between the operator computer and the test bench is established. 
This is done by using a SSH connection. When the connection is made, then a Python 
script is run by the user interface testing software called Squish. Squish is a software 
developed by the Froglogic. Squish will set the parameters for the exposure, which are 
right laterality, Molybdenum track and filter and 26 kV voltage, 4 mAs current-time prod-
uct. If for some reason this isn’t done, then in the next if condition this possibility of error 
is checked. Error handling is described in detail in the next parts of the sequence. 
 
Also a timer is initialized to check that all ten exposures are made in less than an hour 
as specified in the test requirements. After setup, the main part of the subsequence is 
executed. A figure 11 shows the TestStand steps for the sequence main. 
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Figure 11 Sequence Main for Manual mode 
 
The main of the Dose Reproducibility Manual mode subsequence has a while loop which 
is run until ten exposures are made or the timer for one hour has run out. 
 
Exposure is taken with the parameters set before, this is made by controlling digital In-
put/Output (I/O) lines from the test bench. On a console module, which is used to take 
the exposure there are two buttons. First there is the preparation button, which basically 
loads the tube and then the X-ray button which activates the tube for the exposure. The 
prep button is set on first, then after couple of seconds the x-ray button is turned on. After 
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the buttons are pressed, error handler checks if the step was executed without any er-
rors. 
 
After the exposure has been taken, the dose must be read from the dosimeter. This is 
made by a serial connection. Dosimeter value is read into the array to make the calcula-
tions a bit easier in the upcoming part. If dosimeter doesn’t give any reading for the dose, 
the sequence will fail. After the dosimeter reading, the sequence checks the timer if one 
hour has been elapsed since the beginning of the loop. If one hour has been elapsed the 
sequence will fail because of the requirement that ten exposures must be taken in less 
than an hour. 
 
Squish will then set the laterality again on the Console application, so that next exposure 
can be made. After each exposure the selected laterality of right breast needs to be set 
again in order to take another exposure. 
 
This loop will run for ten times if there is no error coming from the steps. After the loop 
has run, the calculations for the reproducibility can be made. This is done by a code 
developed with National Instruments LabVIEW software. The call to the LabVIEW code 
is the step on top of the figure 12 which shows the second part of the Main inside the 
Dose Reproducibility Manual Mode –subsequence. 
 
Figure 12 Second part of the Main in Dose Reproducibility Manual Mode 
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LabVIEW has two views, the front panel which shows the indicators, controls and other 
parameters that can be viewed during the code execution. LabVIEW front panel for 
DoseCalculations.vi can be seen in the figure 13 below. 
 
 
Figure 13 DoseCalculations.vi Front Panel 
 
At the left side is the input array which contains the raw dose values from the dosimeter. 
Since dosimeter uses cumulative mode as measurement mode, the dose value adds to 
the one taken before. Because of this, the value for individual dose must be calculated 
out of the cumulative values. This is done inside a subVI Dose Value which is seen as 
the next block in the block diagram which is seen in the figure 14. 
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Figure 14 DoseCalculations.vi block diagram 
 
The front panel for DoseValues.vi is highly similar with the front panel of DoseCalcula-
tions.vi since they both share the same input and output. The front panel for DoseVal-
ues.vi can be seen in the figure 15 below. 
 
 
Figure 15 DoseValues.vi front panel 
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Inside the block diagram for DoseValues.vi, there is an error case loop in case an error 
comes in to the block diagram. Inside the error loop, there is a for-loop which runs as 
many times as there are dose values, which in this case is ten times. Inside of the for-
loop, there is a case which decides based on the iteration number of the for-loop, which 
case to execute. Cases are 0 and from 1 to 9, since the iteration for the for loop starts 
from zero. With the first value in the array, the dose is already the dose for the single 
exposure, so that value is pushed straight out. Image for this case is seen in the figure 
16 below. 
 
 
Figure 16 Case 0 inside the DoseValues.vi 
 
From the second value onwards, the case 1...9 will execute. Inside the loop the value 
before is subtracted from the current value. So the first value is subtracted from the sec-
ond, second from the third and so on until the iteration comes to ninth value which is the 
dose value for the tenth exposure. After the loop values are added back into the array 
and outputted out of the subVI. The whole block diagram of the DoseValues.vi is seen 
in the figure 17 below.  
 
 
Figure 17 Block diagram for DoseValues.vi 
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The dose values for the each exposure are now in an array which is then inputted into 
the Reproducibility.vi. The front panel of the Reproducibility.vi is seen in the figure 18. 
 
 
Figure 18 Reproducibility.vi LabVIEW Front Panel 
 
Reproducibility.vi will first calculate the average dose value from the ten dose values 
taken before. The average dose value is extracted from the single dose value and the 
result is then powered to 2. This is done for all the ten dose values inside a for-loop. 
Results are added together and then divided by the amount of dose values minus one. 
This value is called the Sigma. Sigma is squared and then sigma is divided by the aver-
age dose value to get the dose reproducibility. Reproducibility.vi block diagram is shown 
in the next figure 19. 
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Figure 19 Reproducibility.vi block diagram 
 
The formulas for calculating reproducibility can be seen below. (Equations 11-13) 
 
𝐴𝑉𝐸𝑅𝐴𝐺𝐸 =  
∑ 𝐷𝑂𝑆𝐸𝑘𝑛𝑘=1
𝑛
      
 
σ = √
∑ (𝐷𝑂𝑆𝐸𝑘 −𝐴𝑉𝐸𝑅𝐴𝐺𝐸)2
𝑛
𝑘=1
𝑛−1
     
 
 𝐶1 =
 σ
𝐴𝑉𝐸𝑅𝐴𝐺𝐸
     
 
The reproducibility value is brought back to TestStand sequence from the LabVIEW 
code. Next step is to save all the dose values to the electronic Device History Record 
(eDHR). This is a regulatory requirement to save all the dose values of the exposures 
taken in this test. The reproducibility value is also saved into the eDHR with the Set-
FieldValue-step. Also the values are written into the log file for easier review of the exe-
cution afterwards. Reproducibility is then evaluated against the regulations, where the 
limit of reproducibility is to be lower than 0.05. The result of the test is saved into the 
eDHR. The steps discussed in this chapter are seen in the figure 12 on page 26. 
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This concludes the Main of the subsequence. Cleanup for the subsequence contains the 
error handling. A select-structure is used to determine which error happened during the 
execution. Cases are numbered in the steps and the error cases are: 
- 0, no error 
- 1, Squish didn’t set parameters on the console application 
- 2, Exposure was not taken 
- 3, Dosimeter value was zero or empty 
- 4, timeout occurred, which means that over an hour elapsed in taking 10 expo-
sures 
- 5, the reproducibility value was not below the regulatory requirement of 0.05 
 
If an error occurred, it will be written into the log file for debugging. With the reproducibility 
value being over the limit, it is also recorded into the eDHR. 
 
3.2.2 Dose Linearity 
 
After the Dose Reproducibility subsequence, another subsequence is executed. Dose 
Linearity has the same kind of structure inside as the Dose Reproducibility, but of course 
there is no reproducibility calculations so therefore the LabVIEW code is a bit different.  
 
The LabVIEW code run is actually just part of the DoseCalculations.vi which was used 
in the first subsequence. For linearity the dose values must be taken from the cumulative 
dose, which is done inside the DoseValues.vi discussed in the chapter before and shown 
in the figure 16. 
 
When dose values are in the array, those can be now imported into eDHR. Next step in 
the sequence is to calculate M Configuration and the average dose value. This is done 
inside a statement step, which is a step in TestStand where variables can be initialized, 
modified etc. in the so called Step Expression. 
 
The average dose value is calculated by getting the sum of 10 doses from the for-loop 
before and dividing the sum by ten, which is the amount of dose values collected. This 
value is saved into a local variable, which can be then used in calculating the M Config1. 
M Config1 is calculated by dividing the previously calculated average dose value and 
dividing it by the current-time product configuration that was used in the first Linearity 
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configuration. Current-time product for configuration 1 was 4 mAs. Formulas 11 & 14 
behind the M Config calculations are shown below:  
 
𝐴𝑉𝐸𝑅𝐴𝐺𝐸 =  
∑ 𝐷𝑂𝑆𝐸𝑘𝑛𝑘=1
𝑛
         
 
M_config1=
𝐴𝑉𝐸𝑅𝐴𝐺𝐸𝐶𝑜𝑛𝑓𝑖𝑔1
𝑚𝐴𝑠𝐶𝑜𝑛𝑓𝑖𝑔1
                 
 
To get the Linearity of the dose, two sets of dose values must be collected. So the steps 
above are duplicate in the configuration 2 with the exception that the current-time product 
is changed into the next value available in the Console application. Current-time product 
for configuration 2 is therefore 4.5 mAs. 
 
Linearity of the dose can now be calculated with the two M configurations collected be-
fore. The formula 16 for calculating Linearity was:  
 
L = 
| 𝑀𝐶𝑜𝑛𝑓𝑖𝑔1− 𝑀𝐶𝑜𝑛𝑓𝑖𝑔2|
𝑀𝐶𝑜𝑛𝑓𝑖𝑔1+ 𝑀𝐶𝑜𝑛𝑓𝑖𝑔2
     
 
Linearity of the dose is then compared to the value set by the regulations. Linearity of 
the dose cannot exceed the amount of 0.1. 
 
3.2.3 Dose Reproducibility Automatic Mode 
 
Last part of the Dose Reproducibility sequence is to calculate reproducibility while using 
the automatic mode. In automatic mode, the parameters of the exposure, track/filter, 
voltage and current-time product are set automatically by the system. The subsequence 
follows the same structure as the Dose Reproducibility subsequence in the chapter 3.2.1. 
 
Only part different is the setting of parameters on the Console application. The mode 
needs to be changed into AOP STD which is the automatic mode with standard breast. 
Then laterality is set to either left or right, all the other parameters are set by the auto-
matic exposure mode. Reproducibility is then calculated with the LabVIEW code and 
compared to the regulations. 
 
34 
 
 
In the cleanup for the sequence the status of the test is determined. If at any point of the 
execution an error is detected the sequence will fail. If the reproducibility, or the linearity 
values are not below the values set by the regulations, the sequence will fail. The se-
quence status is saved into the eDHR. The I/O lines are set to zero if for some reason 
some line was left open because of an error in the execution. Also the communications 
between the dosimeter and the test bench is closed. The CAN bus communication is 
also closed in the cleanup. End of the sequence is written into the log file in AddToLog-
step. If the system noticed an error from the product under test, the error will be noticed 
in the so called asynchronous actions that are monitored from the CAN bus. This is the 
last part of the sequence. Sequence cleanup is seen in the figure 20 below:  
 
 
Figure 20 Sequence Cleanup 
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4 Discussion 
 
Manufacturing lines across the medical device industry are focusing heavily on automa-
tion, and this includes the testing of the equipment. This includes robotics, automated 
testing software and tools to remove operator interactions during the tests. That is what 
has been the goal in Dose Reproducibility & Linearity test, to have an automated test 
with minimal operator interactions. 
 
In this test the operator needs to install equipment in the beginning of the test but after 
equipment is on the correct place, then there is not any actions for the operator to per-
form. In this test the error cases are well handled so if for some reason an error occurs 
it will be relatively easy to locate and fix on the manufacturing line by the operator or the 
manufacturing engineer. 
 
TestStand provides a test report of each execution which shows the status of all the 
steps ran, this indicates if a certain step has passed or failed or given an error. This 
report file is saved into the hard drive on the testbench for further review if needed. 
 
In the past all the history records of the manufacturing process were documented in a 
printed form. This caused a lot of extra work for operator to document all the steps in a 
document, and for storing those documents. That’s why electronic Device History Rec-
ords (eDHR) are used nowadays. All the steps from the beginning of the manufacturing 
process, the assembly of the product, which parts were installed, which parts were 
tested, test results, until the complete product and packaging is documented in the 
eDHR.  
 
In this test the dose values read by the dosimeter are documented into the eDHR as well 
as the calculated values of reproducibility and linearity. Also the result of the test is doc-
umented. All the information from this test is saved into a file which is then, in the end of 
the sequence, uploaded into the eDHR system automatically. In the testing process, the 
eDHR system is a web-based program which shows all the tests and their correct exe-
cution order in the testing process of a mammography system. 
 
Before the Dose Reproducibility & Linearity test can be executed, multiple tests for the 
product must be done prior to this. First the mammography device movements must be 
calibrated. This includes the lift, compression, rotation and angulation rotation. These 
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calibrations need to be tested afterwards to verify that the calibrations were performed 
correctly. Focusing on the x-ray perspective, the Half-Value Layer HVL needs to be cal-
ibrated, the tube filaments need to be tested so that the generator is performing on an 
acceptable level. After the x-ray parameters of the device have been tested the focus 
will be on image quality and various aspects of the detectors performance.  
 
The design of the test sequence is not finalized yet, there might some modifications be-
fore reaching the manufacturing line, but the structure of the test is going to be like men-
tioned in this thesis since this test is specified in the regulations.  
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5 Conclusions 
 
This thesis was made for GE Healthcare Finland Oy. Test engineering department in 
Finland is designing a new mammography testing equipment for GE Healthcare’s man-
ufacturing line in Buc, France. 
 
In mammography examination the most critical part for concerning patient safety is the 
x-ray dose from the exposures. The exposure must be taken with the best possible con-
figuration in order to have a successful image with good enough image quality and in the 
same time to expose the patient to lowest dose possible. Digital mammography has been 
able to reduce the dose as well as improve the image quality of mammography. 
 
In dose reproducibility and linearity test the main criteria is to make sure that with the 
same parameters of the exposure the dose will be same for each performed exposure. 
The dose produced by the x-ray exposure needs to be consistent.  
 
Test sequence designed for this test was developed with the National Instruments 
TestStand software. TestStand is a test management software where engineers can 
manage and run automated tests for the system under test. From the recorded dose 
values of each exposure, the reproducibility and linearity were calculated with National 
Instruments LabVIEW program.  
 
Dose reproducibility and linearity test made for this thesis had an important aspect of 
engineering in mind, the automation of the testing process. This was achieved rather well 
in the test sequence. Operator must only place the dosimeter and the tools needed for 
the test in the beginning and everything else has been automated. Automation includes: 
creating the patient, setting exposure parameters, taking the actual exposure and re-
peating the imaging process to acquire all the necessary dose values and then calculat-
ing the reproducibility and linearity. 
 
Test sequence still needs to be qualified and verified before it can be used on the man-
ufacturing line, which are the next steps in the future. 
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